Tumors may not evolve gradually, but in staccato bursts; Yale nets $12M for brain tumor research;

Cancer Research

> UC Irvine's Dr. Bang Hoang and colleagues have been presented the 2011 Kappa Delta Ann Doner Vaughan Award for their work advancing the understanding of how bone cancer spreads. The award, which comes with a $20,000 grant, was announced at the recent American Academy of Orthopaedic Surgeons annual meeting. Report

> A Turkish financier whose close friend and business associate is being treated for brain cancer has donated $12 million to help Yale University's brain tumor research efforts. Story

> A new method of analyzing cancerous tumors developed by scientists at Cold Spring Harbor Laboratory suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like bursts. It is a finding that has already shed new light on the process of tumor growth and metastasis, and may help in the development of new methods to clinically evaluate tumors. Release

Genetics

> Researchers have new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients. The new study identifies 15 genetic regions that affect a person's risk of developing the disease. Release

> A prostate cancer patient and his three sons are helping to track down the genetic flaws that give some men a higher chance of developing the disease. Story

> Research completed into the genetics of Canine Inflammatory Bowel Disease. Item

Stem Cells

> Bone marrow stem cells may help treat traumatic brain injuries. Report

> Embryonic stem cells, patents and the EU--an update. Story

> Using stem cells, scientists at the Cambridge hospital's ophthalmology clinic have been able to alter tissue taken from bone marrow and graft it to damaged nerves in the eye. With healthy cells in place, the eye is able to repair itself and full vision can return. More here

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.